[Anticoagulants in pregnancy and puerperium].
D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D001779:Blood Coagulation Factors / Q000032:analysis; D001942:Breast Feeding; D003374:Coumarins / Q000627:therapeutic use; D005260:Female; D005865:Gestational Age; D006493:Heparin / Q000627:therapeutic use; D006496:Heparinoids / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D010920:Placenta / Q000378:metabolism; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D011644:Puerperal Disorders / Q000517:prevention & control*; D013300:Streptokinase / Q000378:metabolism / Q000627:therapeutic use; D013923:Thromboembolism / Q000188:drug therapy* / Q000517:prevention & control; D013924:Thrombophlebitis / Q000188:drug therapy
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D003374:Coumarins; D006496:Heparinoids; D006493:Heparin; D013300:Streptokinase
Antikoagulantien in der Schwangerschaft und im Wochenbett.